Clinical characteristics and prediction of pulmonary hypertension in severe emphysema

Respiratory Medicine

Volumn 108, Issue 3, 2014, Pages 482-490

  Minai, Omar A ^a   Fessler, Henry ^b   Stoller, James K ^a   Criner, Gerard J ^c   Scharf, Steven M ^d   Meli, Yvonne ^a   Nutter, Benjamin ^a   Decamp, Malcolm M ^e  

^a LERNER RESEARCH INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c TEMPLE UNIVERSITY   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Chronic obstructive pulmonary disease; Emphysema; Hypoxemia; Lung disease; Pulmonary hypertension

Indexed keywords

CARBON MONOXIDE;

AGED; ARTICLE; BODY MASS; CARBON DIOXIDE TENSION; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; FORCED EXPIRATORY VOLUME; HEART INDEX; HUMAN; LUNG DIFFUSION CAPACITY; LUNG EMPHYSEMA; LUNG FUNCTION; LUNG HEMODYNAMICS; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; OXYGEN TENSION; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RECEIVER OPERATING CHARACTERISTIC; RESIDUAL VOLUME; SENSITIVITY AND SPECIFICITY; SNORING; SYSTOLIC BLOOD PRESSURE; TOTAL LUNG CAPACITY;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; EMPHYSEMA; HYPOXEMIA; LUNG DISEASE; PULMONARY HYPERTENSION;

AGED; CARBON MONOXIDE; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; OXYGEN; PREVALENCE; PULMONARY ARTERY; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84896689362     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2013.11.006     Document Type: Article

References (29)

1. O.A. Minai, A. Chaouat, and S. Adnot Pulmonary hypertension in COPD: epidemiology, significance, and treatment Chest 137 2010 39S 51S
2. S.M. Scharf, M. Iqbal, C. Keller, G. Criner, S. Lee, and H.E. Fessler Hemodynamic characterization of patients with severe emphysema Am J Respir Crit Care Med 166 2002 314 322
3. M.R. Fisher, G.J. Criner, A.P. Fishman, P.M. Hassoun, O.A. Minai, Sm Scharf, H.E. Fessler NETT Research Group Estimating pulmonary artery pressures by echocardiography in patients with emphysema Eur Respir J 30 2007 914 921
4. O.A. Minai, G.J. Criner, S.M. Scharf, H. Fessler, Y. Meli, B. Nutter, and M. DeCamp Pulmonary hemodynamics in moderate to severe emphysema: characteristics and predictors Am J Respir Crit Care Med 181 2010 A5248
5. The National Emphysema Treatment Trial Group Rationale and design of the National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group Chest 116 1999 1750 1761
6. R. Kaw, P. Sharma, and O. Minai What risks does a history of pulmonary hypertension present for patients undergoing noncardiac surgery Cleve Clin J Med 74 2007 S20 S21
7. N. Galie, A. Torbicki, R. Barst, P. Dartevelle, S. Haworth, T. Higenbottam, H. Olschewski, A. Peacock, G. Pietra, L.J. Rubin, G. Simonneau, S.G. Priori, M.A. Garcia, J.J. Blanc, A. Budaj, M. Cowie, V. Dean, J. Deckers, E.F. Burgos, J. Lekakis, B. Lindahl, G. Mazzotta, K. McGregor, J. Morais, A. Oto, O.A. Smiseth, J.A. Barbera, S. Gibbs, M. Hoeper, M. Humbert, R. Naeije, J. Pepke-Zaba, and Task Force Guidelines on diagnosis and treatment of pulmonary arterial hypertension Eur Heart J 25 2004 2243 2278
8. M.M. Hoeper, S. Andreas, A. Bastian, M. Claussen, H.A. Ghofrani, M. Gorenflo, C. Grohé, A. Günther, M. Halank, P. Hammerl, M. Held, S. Krüger, T.J. Lange, F. Reichenberger, A. Sablotzki, G. Staehler, W. Stark, H. Wirtz, C. Witt, and J. Behr Pulmonary hypertension due to chronic lung disease: updated recommendations of the Cologne Consensus Conference 2011 Int J Cardiol 154 Suppl. 1 2011 S45 S53
9. E. Weitzenblum, A. Sautegeau, M. Ehrhart, M. Mammoser, C. Hirth, and E. Roeget Long-term course of pulmonary arterial pressure in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 130 1984 993 998
10. M. Oswald-Mammoser, M. Apprill, P. Bachez, M. Ehrhart, and E. Weitzenblum Pulmonary hemodynamics in chronic obstructive pulmonary disease of the emphysematous type Respiration 58 1991 304 310
11. G. Thabut, G. Dauriat, J.B. Stern, D. Logeart, A. Lévy, R. Marrash-Chahla, and H. Mal Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation Chest 127 2005 1531 1536
12. A. Chaouat, R. Naeije, and E. Weitzenblum Pulmonary hypertension in COPD Eur Respir J 32 2008 1371 1385
13. R. Naeije Pulmonary hypertension and right heart failure in chronic obstructive pulmonary disease Proc Am Thorac Soc 2 2005 20 22
14. A. Chaouat, A.-S. Bugnet, N. Kadaoui, R. Schott, I. Enache, A. Ducolone, M. Ehrhart, R. Kessler, and E. Weitzenblum Severe pulmonary hypertension and chronic obstructive pulmonary disease Am J Respir Crit Care Med 172 2005 189 194
15. V. Cottin, J. Le Pavec, G. Prevot, H. Mal, M. Humbert, G. Simonneau, J.-F. Cordier, and GERM 'O'P Pulmonary hypertension in patients with combined pulmonary fibrosis and emphysema syndrome Eur Respir J 35 2010 105 111
16. D. Stolz, H. Rasch, A. Linka, M. Di Valentino, A. Meyer, M. Brutsche, and M. Tamm A randomised, controlled trial of bosentan in severe COPD Eur Respir J 32 2008 619 628
17. M.M. Hoeper Treating pulmonary hypertension in COPD: where do we start? Eur Respir J 32 2008 541 542
18. H. Rietema, S. Holverda, H.J. Bogaard, J.T. Marcus, H.J. Smit, N. Westerhof, P.E. Postmus, A. Boonstra, and A. Vonk-Noordegraaf Sildenafil treatment in COPD does not affect stroke volume or exercise capacity Eur Respir J 31 2008 759 764
19. C. Casanova, C. Cote, J.P. de Torres, A. Aguirre-Jaime, J.M. Marin, V. Pinto-Plata, and B.R. Celli Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease Am J Respir Crit Care Med 171 2005 591 597
20. J.W. Lankhaar, N. Westerhof, T.J. Faes, K.M. Marques, J.T. Marcus, P.E. Postmus, and A. Vonk-Noordegraaf Quantification of right ventricular afterload in patients with and without pulmonary hypertension Am J Physiol Heart Circ Physiol 291 2006 H1731 H1737
21. J.A. Barbera, A. Riverola, J. Roca, J. Ramirez, P.D. Wagner, D. Ros, B.R. Wiggs, and R. Rodriguez-Roisin Pulmonary vascular abnormalities and ventilation-perfusion relationships in mild chronic obstructive pulmonary disease Am J Respir Crit Care Med 149 1994 423 429
22. R.G. Barr, D.A. Bluemke, F.S. Ahmed, J.J. Carr, P.L. Enright, E.A. Hoffman, R. Jiang, S.M. Kawut, R.A. Kronmal, J.A. Lima, E. Shahar, L.J. Smith, and K.E. Watson Percent emphysema, airflow obstruction, and impaired left ventricular filling N Engl J Med 362 2010 217 227
23. S. Krachman, O.A. Minai, and S.M. Scharf Sleep abnormalities and treatment in emphysema Proc Am Thorac Soc 5 2008 536 542
24. E. Weitzenblum, A. Sautegeau, M. Ehrhart, M. Mammosser, and A. Pelletier Long-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary disease Am Rev Respir Dis 131 1985 493 498
25. D.A. Zisman, A.S. Karlamangla, D.J. Ross, M.P. Keane, J.A. Belperio, R. Saggar, J.P. Lynch 3rd, A. Ardehali, and J. Goldin High-resolution chest CT findings do not predict the presence of pulmonary hypertension in advanced idiopathic pulmonary fibrosis Chest 132 2007 773 779
26. J.B. Haimovici, B. Trotman-Dickenson, E.F. Halpern, G.W. Dec, L.C. Ginns, J.O. Shepard, and T.C. McLoud Relationship between pulmonary artery diameter at computed tomography and pulmonary artery pressures at right-sided heart catheterization Acad Radiol 4 1997 327 334
27. C.S. Ng, A.U. Wells, and S.P.G. Padley A CT sign of chronic pulmonary arterial hypertension: the ratio of main pulmonary artery to aortic diameter J Thorac Imaging 14 1999 270 278
28. X.G. Sun, J.E. Hansen, R.J. Oudiz, and K. Wasserman Pulmonary function in primary pulmonary hypertension J Am Coll Cardiol 41 2003 1028 1035
29. V.D. Steen, G. Graham, C. Conte, G. Owens, and T.A. Medsger Jr. Isolated diffusion capacity reduction in systemic sclerosis Arthritis Rheum 35 1992 765 770